Electronic AKI Alert vs Usual Care: Number of Subjects With Chart Documentation of AKI

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measure	Value	95% interval, lower	95% interval, upper	Method	Source
Risk in group 1	0.7	0.683	0.716	wilson	ClinicalTrials.gov
Risk in group 2	0.63	0.612	0.647	wilson	ClinicalTrials.gov
Risk difference, group 1 minus group 2	0.0701	0.0463	0.0939	newcombe hybrid score	ClinicalTrials.gov
Risk ratio, group 1 over group 2	1.11	1.07	1.15	log	ClinicalTrials.gov
Odds ratio, group 1 over group 2	1.37	1.23	1.53	log	ClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Electronic AKI Alert than on Usual Care	14.3	10.7	21.6	from the risk difference interval	ClinicalTrials.gov

Groups 2

Group 2 names the comparator: usual care.

Group	Title	Description	With the outcome	Analysed	ClinicalTrials.gov code	Source
Group 1	Electronic AKI Alert	A pop-up alert will fire when a provider opens the electronic health record of a patient with AKI until such time as AKI is documented in the problem list, or AKI resolves.~AKI Alert: Provider's will receive a pop-up alert in the electronic health record until AKI is documented in the problem list or AKI resolves.	2,141	3,059	OG001	ClinicalTrials.gov
Group 2	Usual Care	No alert will be fired.	1,871	2,971	OG000	ClinicalTrials.gov

Outcome 5

Field	Value	Source
Type	SECONDARY	ClinicalTrials.gov
Title	Number of Subjects With Chart Documentation of AKI	ClinicalTrials.gov
Description	Proportion of subjects with chart documentation of AKI by post-discharge ICD-10 codes and by chart adjudication	ClinicalTrials.gov
Time frame	Index hospitalization	ClinicalTrials.gov
Population	Chart documentation via ICD-10 codes (code N17) have been collected. Documentation via chart adjudication has not yet been collected.	ClinicalTrials.gov

Trial 8

Field	Value	Source
Title	Optimizing Electronic Alerts for Acute Kidney Injury	ClinicalTrials.gov
NCT number	NCT02753751	ClinicalTrials.gov
Phases	NA	ClinicalTrials.gov
Conditions	Acute Kidney Injury	ClinicalTrials.gov
Interventions	AKI Alert	ClinicalTrials.gov
Lead sponsor	Yale University	ClinicalTrials.gov
Results first posted	2022-02-10	ClinicalTrials.gov
Results on ClinicalTrials.gov	https://clinicaltrials.gov/study/NCT02753751?tab=results	ClinicalTrials.gov

Source 4

Field	Value	Source
Release	trial-comparisons-2026-03-23-0.1.0	ClinicalTrials.gov
Release manifest SHA-256	f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57	ClinicalTrials.gov
AACT copy	2026-03-23	ClinicalTrials.gov
Tables read	outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet	ClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.